Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Bristol-Myers Squibb Announces Dividend
September 17, 2015 4:32 PM EDTNEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers... More
Bristol-Myers Squibb’s Opdivo (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Advanced Renal Cell Carcinoma
September 16, 2015 8:01 AM EDTDesignation based on positive results of the Phase 3 study, CheckMate -025, reinforcing significant unmet medical need in this patient population
CheckMate -025 marks the first time any agent has demonstrated, as a primary endpoint, an overall survival benefit vs. standard of care in second-line metastatic renal cell carcinoma
PRINCETON, N.J.--(BUSINESS WIRE)--... More
